Literature DB >> 29765947

Leser-Trélat Syndrome in a Male with Breast Carcinoma and Eyelid Basal Cell Carcinoma.

Rajiv Garg1, Siddharth Madan1, Pragya Prakash1, Ram Chander2, Monisha Choudhary3.   

Abstract

PURPOSE: Leser-Trélat syndrome consists of appearance of a solid tumor-like carcinoma breast, colon, or stomach following eruption of multiple seborrheic keratoses (SK) of the skin. We present an unusual and possibly the first case report of Leser-Trélat syndrome in a male patient with a history of mastectomy for breast carcinoma who presented to us with a second malignancy in the form of basal cell carcinoma (BCC) of the lower eyelid. PROCEDURE: A 75-year-old male presented in 2014 with a history of modified radical mastectomy for infiltrating ductal carcinoma of the left breast which was performed 11 years prior to the day of presentation. Breast carcinoma was diagnosed following eruption of multiple SK at the same time. In the previous 3 years he noted a nodulo-ulcerative growth over the lateral aspect of the right lower eyelid which was clinically diagnosed as BCC. Mass excision under frozen section control and lid reconstruction was performed. Diagnosis of BCC was confirmed on histopathological examination of the excised specimen. RESULTS AND
CONCLUSIONS: Though a previously unobserved entity, our case supports the importance of Leser-Trélat sign and its relevance to affected individuals, as early recognition and prompt treatment of a low-stage cancer offers good prognosis.

Entities:  

Keywords:  Basal cell carcinoma; Breast carcinoma; Eyelid malignancies; Leser-Trélat syndrome; Tenzel flap

Year:  2017        PMID: 29765947      PMCID: PMC5939681          DOI: 10.1159/000481354

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  12 in total

1.  Seborrhoeic keratoses and internal malignancies. A case control study.

Authors:  L E Schwengle; F H Rampen; T Wobbes
Journal:  Clin Exp Dermatol       Date:  1988-05       Impact factor: 3.470

2.  Studying regression of seborrheic keratosis in lichenoid keratosis with sequential dermoscopy imaging.

Authors:  Pedro Zaballos; Elisabeth Salsench; Patricia Serrano; Francisco Cuellar; Susana Puig; Josep Malvehy
Journal:  Dermatology       Date:  2009-12-09       Impact factor: 5.366

3.  Sign of Leser-Trélat: report of two cases and review of the literature.

Authors:  P Y Venencie; H O Perry
Journal:  J Am Acad Dermatol       Date:  1984-01       Impact factor: 11.527

4.  Eyelid reconstruction by the semicircle flap technique.

Authors:  R R Tenzel; W B Stewart
Journal:  Ophthalmology       Date:  1978-11       Impact factor: 12.079

5.  The relation between seborrheic keratoses and malignant solid tumours. A case-control study.

Authors:  J J Grob; M C Rava; J Gouvernet; P Fuentes; L Piana; M Gamerre; J C Sarles; J J Bonerandi
Journal:  Acta Derm Venereol       Date:  1991       Impact factor: 4.437

6.  Seborrheic keratoses and cancer.

Authors:  B Lindelöf; B Sigurgeirsson; S Melander
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

Review 7.  Sign of Leser-Trélat.

Authors:  R A Schwartz
Journal:  J Am Acad Dermatol       Date:  1996-07       Impact factor: 11.527

8.  [Acanthosis nigricans maligna and Leser-Trélat sign in double malignancy of the breast and stomach].

Authors:  W Stieler; G Plewig
Journal:  Z Hautkr       Date:  1987-03-01

9.  Leser-Trelat sign.

Authors:  Can Ceylan; Sibel Alper; Işil Kilinç
Journal:  Int J Dermatol       Date:  2002-10       Impact factor: 2.736

10.  Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers.

Authors:  Giovanni Ponti; Gabriele Luppi; Lorena Losi; Alberto Giannetti; Stefania Seidenari
Journal:  J Hematol Oncol       Date:  2010-01-11       Impact factor: 17.388

View more
  1 in total

1.  Leser-Trelat sign preceding male breast cancer.

Authors:  Soraya Aouali; Sara Bensalem; Hasnae Saddouk; Asmae Aissaoui; Amal Bennani; Nada Zizi; Siham Dikhaye
Journal:  Ann Med Surg (Lond)       Date:  2021-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.